| Q38116034 | Animal models of efficacy to accelerate drug discovery in malaria |
| Q28544002 | Comparative analysis of field-isolate and monkey-adapted Plasmodium vivax genomes |
| Q36225484 | Cryopreserved Plasmodium vivax and cord blood reticulocytes can be used for invasion and short term culture |
| Q35213885 | Development and evaluation of a prototype non-woven fabric filter for purification of malaria-infected blood |
| Q42234691 | Evaluation of the Safety and Biodistribution of M032, an Attenuated HSV-1 Virus Expressing hIL-12, After Intracerebral Administration to Aotus Non-Human Primates |
| Q33720628 | Evaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates |
| Q48008497 | Gamma interferon levels and antibody production induced by two PvMSP-1 recombinant polypeptides are associated with protective immunity against P.vivax in Aotus monkeys |
| Q62606255 | The T-cell receptor in primates: identifying and sequencing new owl monkey TRBV gene sub-groups |
| Q44169674 | The evolution of virulence and host specialization in malaria parasites of primates |
| Q41929335 | Use of a rhesus Plasmodium cynomolgi model to screen for anti-hypnozoite activity of pharmaceutical substances |